Bhuamik Pandya,Blaise Lippa,Xin Zhang,Jon Christian Baber,Jan Antionette C. Romero,Jing Zhang
申请号：
US15501103
公开号：
US20170216295A1
申请日:
2015.07.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided herein are compounds that inhibit CCR9 receptor function. Also provided herein are methods of treating inflammatory disease in a subject, comprising administering to the subject a compound of the invention. Accordingly, in one aspect, provided herein is a compound of Formula (1) or a pharmaceutically acceptable salt thereof. In another aspect, provided herein is a pharmaceutical composition, comprising a compound of Formula (1), and a pharmaceutically acceptable carrier.
